Coeptis Therapeutics, Inc. (COEP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 5.91M | 7.35M | 5.99M | 3.69M | 4.65M | 1.05M | 1.36M | 1.99M | 1.38M | 1.75M | 1.62M | 3.8M |
| Cash & Short-Term Investments | 5.26M | 6.35M | 5.33M | 2.99M | 4.27M | 532.88K | 1.14M | 1.56M | 1.03M | 1.47M | 1.41M | 3.24M |
| Cash Only | 5.21M | 5.67M | 4.91M | 2M | 4.27M | 532.88K | 1.14M | 1.56M | 1.03M | 1.47M | 1.41M | 3.24M |
| Short-Term Investments | 50.55K | 676.6K | 421.7K | 990.57K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 15.29K | 7.35K | 86.04K | 30K | 0 | 0 | 0 | 191.08K | 108.58K | 38.98K | 833 | 0 |
| Days Sales Outstanding | 8.95 | 4.98 | 22.48 | 13.6 | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 350K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 631.08K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 13.88M | 12.49M | 10.29M | 8.5M | 8.8M | 7.86M | 7.59M | 9.76M | 8.01M | 6.32M | 5.55M | 3.36M |
| Property, Plant & Equipment | 89.25K | 18.4K | 39.12K | 49.73K | 60.1K | 59.78K | 80.23K | 89.99K | 99.54K | 108.88K | 40.29K | 50.91K |
| Fixed Asset Turnover | 2.11x | 29.97x | 5.34x | 3.65x | 1.05x | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 316.09K | 361.25K | 1.21M | 451.56K | 496.72K | 541.88K | 1.8M | 2.05M | 2.3M | 2.55M | 2.8M | 3.05M |
| Long-Term Investments | 13.16M | 7.86M | 9.04M | 6.94M | 6.94M | 5.69M | 5.69M | 7.55M | 5.5M | 3.5M | 2.5M | 0 |
| Other Non-Current Assets | 313.89K | 4.25M | 0 | 1.05M | 1.3M | 1.56M | 15.83K | 63.33K | 110.83K | 158.33K | 205.83K | 253.33K |
| Total Assets | 19.79M | 19.84M | 16.28M | 12.19M | 13.45M | 8.91M | 8.96M | 11.75M | 9.39M | 8.07M | 7.17M | 7.16M |
| Asset Turnover | 0.01x | 0.05x | 0.02x | 0.02x | 0.01x | - | - | - | - | - | - | - |
| Asset Growth % | 47.08% | 122.71% | 81.8% | 3.77% | 43.2% | 10.38% | 24.9% | 64.18% | 58.09% | 1.96% | -36.34% | 9.69% |
| Total Current Liabilities | 1.82M | 1.77M | 2.71M | 4.48M | 5.65M | 4.51M | 3.44M | 3.63M | 4.3M | 2.99M | 2.23M | 2.51M |
| Accounts Payable | 1.01M | 888.75K | 783.1K | 1.03M | 1.12M | 1.27M | 1.13M | 1.28M | 1.37M | 1.42M | 482K | 395.23K |
| Days Payables Outstanding | 1.89K | 1.7K | 1.85K | 2.17K | 2.38K | - | - | - | - | - | - | - |
| Short-Term Debt | 100K | 118.88K | 129.87K | 1.14M | 1.84M | 1.19M | 1.55M | 1.57M | 2.22M | 1.01M | 1.19M | 1.85M |
| Deferred Revenue (Current) | 485.68K | 599.46K | 0 | 1.63M | 1.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.23M | 161.05K | 1.79M | 235K | 870.49K | 1.28M | 0 | 771.03K | 719.04K | 555.95K | 567.03K | 0 |
| Current Ratio | 3.25x | 4.16x | 2.21x | 0.83x | 0.82x | 0.23x | 0.40x | 0.55x | 0.32x | 0.59x | 0.73x | 1.51x |
| Quick Ratio | 3.25x | 4.16x | 2.21x | 0.83x | 0.82x | 0.23x | 0.40x | 0.55x | 0.32x | 0.59x | 0.73x | 1.37x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 317.63K | 559.5K | 636.12K | 338K | 528.13K | 533.3K | 882.8K | 733.55K | 768.43K | 543.1K | 2.15M |
| Long-Term Debt | 0 | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K |
| Capital Lease Obligations | 0 | 0 | 0 | 18.87K | 18.87K | 18.88K | 61.18K | 61.18K | 61.18K | 61.18K | 14.72K | 14.72K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 167.63K | 409.5K | 467.25K | 169.13K | 359.25K | 322.13K | 671.62K | 522.37K | 557.25K | 378.38K | 1.99M |
| Total Liabilities | 390.53K | 2.09M | 3.26M | 5.11M | 5.99M | 5.04M | 3.97M | 4.51M | 5.03M | 3.76M | 2.78M | 4.67M |
| Total Debt | 100K | 268.88K | 279.87K | 1.33M | 2.04M | 1.4M | 1.77M | 1.78M | 2.43M | 1.22M | 1.35M | 2.04M |
| Net Debt | -5.11M | -5.41M | -4.63M | -664.11K | -2.23M | 866.17K | 637.54K | 229.59K | 1.4M | -244.91K | -61.03K | -1.21M |
| Debt / Equity | 0.01x | 0.02x | 0.02x | 0.19x | 0.27x | 0.36x | 0.36x | 0.25x | 0.56x | 0.28x | 0.31x | 0.82x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -714.41x | -2.68x | -45.30x | -62.94x | -46.85x | -37.30x | -34.91x | -44.95x | -13.97x | -289.95x | -319.73x | -74.12x |
| Total Equity | 17.58M | 17.75M | 13.02M | 7.08M | 7.46M | 3.87M | 4.98M | 7.24M | 4.36M | 4.31M | 4.39M | 2.49M |
| Equity Growth % | 135.55% | 359.11% | 161.26% | -2.21% | 71.19% | -10.36% | 13.42% | 190.8% | 238.99% | -3.13% | -34.86% | 20.79% |
| Book Value per Share | 2.91 | 4.19 | 2.74 | 1.91 | 2.43 | 2.01 | 0.13 | 0.19 | 0.12 | 0.12 | 0.16 | 0.11 |
| Total Shareholders' Equity | 17.18M | 17.25M | 12.47M | 6.1M | 6.48M | 3.19M | 4.82M | 7.11M | 4.36M | 4.31M | 4.39M | 2.49M |
| Common Stock | 656 | 575 | 516 | 416 | 337 | 212 | 4K | 3.97K | 3.64K | 3.53K | 3.3K | 2.44K |
| Retained Earnings | -113.87M | -109.95M | -108.38M | -105.99M | -101.65M | -98.23M | -95.22M | -93.39M | -90.36M | -87.36M | -83.6M | -76.72M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 401.88K | 506.16K | 551.2K | 984.3K | 984.3K | 682.06K | 157.68K | 132.49K | 0 | 0 | 0 | 0 |